Cargando…
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis
Vaccines against coronavirus 2019 disease (COVID-19) have shown to be greatly effective in preventing viral spread, serious illness and death from this infectious disease and are therefore critical for the management of the COVID-19 pandemic. However, the listing of myocarditis and pericarditis as p...
Autores principales: | Klamer, T. A., Linschoten, M., Asselbergs, F. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906525/ https://www.ncbi.nlm.nih.gov/pubmed/35266090 http://dx.doi.org/10.1007/s12471-022-01677-9 |
Ejemplares similares
-
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
por: Nauck, Michael A.
Publicado: (2013) -
The importance of influenza vaccination during the COVID‐19 pandemic
por: McCauley, John, et al.
Publicado: (2021) -
Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo: Enhanced gene transfer and adjuvant activity
por: Calvet, Christophe Y, et al.
Publicado: (2014) -
Calling for an exponential escalation scheme in vaccine development for COVID-19
por: Wehling, Martin
Publicado: (2020) -
Restrictions on the use of placebo in new COVID-19 vaccine trials
por: Bonati, Maurizio
Publicado: (2021)